Jarmila Kissová

Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status

Blanka Kubešová, Šárka Pavlová, Jitka Malčíková et al. · Leukemia · 2017 · 74 citations · Full text

Increased mean platelet volume and immature platelet fraction as potential predictors of thrombotic complications in BCR/ABL-negative myeloproliferative neoplasms

Jarmila Kissová, Alena Buliková, Petra Ovesná et al. · International Journal of Hematology · 2014 · 34 citations

Thrombopoiesis, Thrombosis, Hematological Malignancy +9

Second malignancies in philadelphia-negative myeloproliferative neoplasms-single-center experience.

Jarmila Kissová, Petra Ovesná, Miroslav Penka et al. · PubMed · 2014 · 25 citations

Increasing hematopoietic microchimerism is a reliable indicator of incipient AML relapse

Ondřej Horký, Jiřı́ Mayer, Lenka Kablásková et al. · International Journal of Laboratory Hematology · 2010 · 24 citations

Thrombosis in thrombocythemic Ph‐ myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide

Petra Ovesná, O Cerná, Jarmila Kissová et al. · European Journal Of Haematology · 2015 · 24 citations · Full text

Immunohematology, Pathology, Anagrelide Treatment +17